| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.
|
Circulation
|
2006
|
4.98
|
|
2
|
Initial evaluation of coronary images from 320-detector row computed tomography.
|
Int J Cardiovasc Imaging
|
2008
|
4.44
|
|
3
|
ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.
|
J Am Coll Cardiol
|
2009
|
3.51
|
|
4
|
Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
|
J Am Coll Cardiol
|
2011
|
2.83
|
|
5
|
Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study.
|
Circulation
|
2008
|
2.77
|
|
6
|
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
|
J Am Coll Cardiol
|
2012
|
2.60
|
|
7
|
Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus.
|
Circulation
|
2012
|
2.33
|
|
8
|
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
|
Circulation
|
2011
|
2.32
|
|
9
|
ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.
|
Circulation
|
2009
|
2.30
|
|
10
|
Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion.
|
J Am Coll Cardiol
|
2011
|
2.23
|
|
11
|
Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease.
|
J Am Coll Cardiol
|
2013
|
2.11
|
|
12
|
Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography.
|
Int J Cardiovasc Imaging
|
2008
|
2.09
|
|
13
|
Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study.
|
Eur Heart J
|
2013
|
1.98
|
|
14
|
Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.
|
JACC Cardiovasc Imaging
|
2009
|
1.93
|
|
15
|
Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2014
|
1.91
|
|
16
|
Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study.
|
J Nucl Med
|
2007
|
1.84
|
|
17
|
Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials.
|
J Am Coll Cardiol
|
2013
|
1.84
|
|
18
|
Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex.
|
JACC Cardiovasc Imaging
|
2011
|
1.83
|
|
19
|
Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses.
|
J Nucl Med
|
2005
|
1.75
|
|
20
|
Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET.
|
J Nucl Med
|
2009
|
1.74
|
|
21
|
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.
|
J Am Coll Cardiol
|
2012
|
1.63
|
|
22
|
Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.
|
JACC Cardiovasc Imaging
|
2012
|
1.61
|
|
23
|
Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I levels and atypical clinical presentation.
|
J Nucl Cardiol
|
2007
|
1.55
|
|
24
|
Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
|
J Nucl Cardiol
|
2012
|
1.55
|
|
25
|
Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry.
|
J Am Coll Cardiol
|
2013
|
1.54
|
|
26
|
Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease.
|
J Am Coll Cardiol
|
2007
|
1.51
|
|
27
|
Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET.
|
J Nucl Cardiol
|
2014
|
1.46
|
|
28
|
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
|
J Am Coll Cardiol
|
2013
|
1.44
|
|
29
|
Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging.
|
Eur Heart J
|
2013
|
1.39
|
|
30
|
Meta-analysis of coronary CT angiography in the emergency department.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
1.39
|
|
31
|
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
|
Circulation
|
2005
|
1.32
|
|
32
|
Should PET replace SPECT for evaluating CAD? The end of the beginning.
|
J Nucl Cardiol
|
2006
|
1.24
|
|
33
|
Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction.
|
J Am Coll Cardiol
|
2007
|
1.21
|
|
34
|
Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease.
|
J Nucl Cardiol
|
2012
|
1.14
|
|
35
|
The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes.
|
J Nucl Cardiol
|
2009
|
1.12
|
|
36
|
Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques.
|
Circ Res
|
2013
|
1.11
|
|
37
|
Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events.
|
Circ Cardiovasc Imaging
|
2014
|
1.10
|
|
38
|
Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction.
|
Circ Cardiovasc Imaging
|
2009
|
1.07
|
|
39
|
SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0.
|
J Nucl Med
|
2013
|
1.04
|
|
40
|
Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing.
|
Circulation
|
2008
|
1.03
|
|
41
|
Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans: A Feasibility Study.
|
J Nucl Med
|
2013
|
1.02
|
|
42
|
Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing.
|
Circulation
|
2008
|
1.02
|
|
43
|
Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.
|
J Nucl Med
|
2014
|
1.01
|
|
44
|
Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.00
|
|
45
|
Integration of coronary anatomy and myocardial perfusion imaging.
|
Nat Rev Cardiol
|
2010
|
1.00
|
|
46
|
Quantitative (82)Rb PET/CT: development and validation of myocardial perfusion database.
|
J Nucl Med
|
2007
|
0.93
|
|
47
|
Assessment of coronary flow reserve and microcirculation: a clinical perspective.
|
J Nucl Cardiol
|
2004
|
0.92
|
|
48
|
Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging.
|
J Am Coll Cardiol
|
2005
|
0.92
|
|
49
|
Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
|
J Nucl Cardiol
|
2013
|
0.90
|
|
50
|
Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.87
|
|
51
|
Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality.
|
Ann Intern Med
|
2008
|
0.85
|
|
52
|
Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.
|
J Nucl Med
|
2013
|
0.85
|
|
53
|
Comparison of cardiac computed tomography examination appropriateness under the 2010 revised versus the 2006 original Appropriate Use Criteria.
|
J Cardiovasc Comput Tomogr
|
2012
|
0.84
|
|
54
|
Cardiometabolic risk is associated with atherosclerotic burden and prognosis: results from the partners coronary computed tomography angiography registry.
|
Diabetes Care
|
2013
|
0.84
|
|
55
|
Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.
|
Am J Cardiol
|
2013
|
0.84
|
|
56
|
Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease.
|
J Nucl Cardiol
|
2006
|
0.83
|
|
57
|
Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease?
|
J Am Coll Cardiol
|
2006
|
0.83
|
|
58
|
Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
|
J Nucl Med
|
2002
|
0.83
|
|
59
|
Nuclear cardiology will remain the "gatekeeper" over CT angiography.
|
J Nucl Cardiol
|
2007
|
0.82
|
|
60
|
Hybrid SPECT/CT and PET/CT imaging: the next step in noninvasive cardiac imaging.
|
Semin Nucl Med
|
2009
|
0.82
|
|
61
|
Coronary microvascular function in early chronic kidney disease.
|
Circ Cardiovasc Imaging
|
2010
|
0.82
|
|
62
|
Comparison of the Diamond-Forrester method and Duke Clinical Score to predict obstructive coronary artery disease by computed tomographic angiography.
|
Am J Cardiol
|
2012
|
0.81
|
|
63
|
Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality.
|
J Cardiovasc Magn Reson
|
2014
|
0.80
|
|
64
|
Impaired skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in patients with peripheral artery disease and intermittent claudication.
|
Arterioscler Thromb Vasc Biol
|
2010
|
0.80
|
|
65
|
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.
|
Am Heart J
|
2005
|
0.80
|
|
66
|
Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy.
|
J Nucl Cardiol
|
2004
|
0.79
|
|
67
|
Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.
|
J Nucl Cardiol
|
2006
|
0.79
|
|
68
|
Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging.
|
J Nucl Cardiol
|
2006
|
0.78
|
|
69
|
Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging.
|
Am J Cardiol
|
2004
|
0.78
|
|
70
|
Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.
|
Curr Cardiol Rep
|
2014
|
0.78
|
|
71
|
The value of noninvasive computed tomography derived fractional flow reserve in our current approach to the evaluation of coronary artery stenosis.
|
Curr Opin Cardiol
|
2016
|
0.78
|
|
72
|
Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure.
|
Curr Heart Fail Rep
|
2008
|
0.77
|
|
73
|
Combined anatomic and perfusion imaging of the heart.
|
Curr Cardiol Rep
|
2010
|
0.77
|
|
74
|
Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis.
|
J Am Coll Cardiol
|
2014
|
0.76
|
|
75
|
Technetium-99m-sestamibi redistribution after exercise stress test identified by a novel cardiac gamma camera: two case reports.
|
Clin Cardiol
|
2010
|
0.76
|
|
76
|
Multimodality imaging of an unusual case of cardiac paraganglioma.
|
J Nucl Cardiol
|
2009
|
0.76
|
|
77
|
Insights into left ventricular remodeling through noninvasive measures of myocardial matrix expansion with cardiovascular magnetic resonance.
|
Circulation
|
2012
|
0.76
|
|
78
|
Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation.
|
J Nucl Cardiol
|
2013
|
0.76
|
|
79
|
Proceedings of the Cardiac PET Summit, 12 May 2014, Baltimore, MD : 3: Quantitation of myocardial blood flow.
|
J Nucl Cardiol
|
2015
|
0.76
|
|
80
|
The quest for myocardial viability: Is there a role for nitrate-enhanced imaging?
|
J Nucl Cardiol
|
2003
|
0.75
|
|
81
|
Reply: all vasodilators are not equal.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
82
|
The art and science of predicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function.
|
J Am Coll Cardiol
|
2002
|
0.75
|
|
83
|
Assessment of myocardial viability after myocardial infarction.
|
J Nucl Cardiol
|
2002
|
0.75
|
|
84
|
Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis.
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
85
|
Editor's note.
|
Circ Cardiovasc Imaging
|
2015
|
0.75
|
|
86
|
Editor's note.
|
Circ Cardiovasc Imaging
|
2013
|
0.75
|
|
87
|
Task Force 5: training in nuclear cardiology: endorsed by the American Society of Nuclear Cardiology.
|
J Am Coll Cardiol
|
2006
|
0.75
|
|
88
|
Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
89
|
Are human readers needed for prognostication from stress myocardial perfusion SPECT? Using outcomes research to validate medical technology.
|
J Nucl Med
|
2005
|
0.75
|
|
90
|
ABNM position statement: Nuclear medicine professional competency and scope of practice.
|
J Nucl Med
|
2011
|
0.75
|
|
91
|
Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease.
|
Curr Opin Cardiol
|
2016
|
0.75
|
|
92
|
Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity.
|
Eur J Nucl Med Mol Imaging
|
2015
|
0.75
|
|
93
|
Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.
|
Curr Cardiol Rep
|
2003
|
0.75
|
|
94
|
Hybrid cardiac imaging: complementary roles of CT angiography and PET in a patient with a history of radiation therapy.
|
J Nucl Cardiol
|
2007
|
0.75
|
|
95
|
Task force 5: training in nuclear cardiology endorsed by the American Society of Nuclear Cardiology.
|
J Am Coll Cardiol
|
2008
|
0.75
|
|
96
|
Correlative imaging of spontaneous coronary artery dissection.
|
J Nucl Cardiol
|
2012
|
0.75
|